Earth Science Tech Inc. (OTC: ETST) held its first annual meeting of stockholders virtually on August 31, 2026, where shareholders approved several key proposals that could significantly alter the company's capital structure and governance. The approvals mark a critical step in the company's strategy to uplist to a national exchange such as Nasdaq or the New York Stock Exchange (NYSE).
Shareholders authorized the Board of Directors to pursue a reverse stock split if deemed necessary to meet the bid price requirements for an uplisting. The authorization is valid for a period of 12 months, giving the Board flexibility to act when market conditions are favorable. A reverse split would reduce the number of outstanding shares and increase the stock price, helping the company satisfy exchange listing standards.
In addition, stockholders authorized the Board's Independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This move would eliminate the current dual-class voting structure, potentially simplifying the company's governance and making it more attractive to institutional investors. The retirement of the Series B Preferred Stock could also align voting rights with economic ownership, a common requirement for national exchange listings.
During the meeting, shareholders also ratified the appointment of Semple, Marchal & Cooper LLP as an independent registered public accounting firm, re-elected seven director nominees, and authorized a new non-dilutive executive compensation framework. These actions further strengthen the company's corporate governance and align executive incentives with shareholder interests.
Giorgio R. Saumat, CEO and Chairman of the Board, emphasized that he will not support a reverse split unless it is absolutely necessary. In a statement, Saumat noted that any decision would be made with careful consideration of shareholder value. The company's newsroom, available at https://ibn.fm/ETST, provides ongoing updates.
The implications of these approvals are substantial. Uplisting to a national exchange like Nasdaq or NYSE would increase ETST's visibility, liquidity, and access to a broader investor base, including institutional investors. It could also lead to improved analyst coverage and potentially a higher valuation. The elimination of the dual-class structure may appeal to investors who prefer one-share-one-vote governance.
However, the reverse split authorization introduces uncertainty for current shareholders, as it could dilute or consolidate their holdings depending on the ratio. The Board's discretion to implement the split within 12 months allows it to time the move strategically, but it also means shareholders face ongoing uncertainty.
ETST operates as a strategic holding company in the healthcare, pharmacy, and telemedicine sector, and these governance changes are part of a broader effort to position the company for growth and enhanced market presence. The retirement of the Series B Preferred Stock, if successfully negotiated, would remove a significant hurdle to uplisting and could streamline decision-making.
Overall, the shareholder approvals signal strong support for management's strategic vision and could set the stage for ETST to join the ranks of national exchange-listed companies, a move that would mark a new chapter for the company and its investors.
